In 2023, BMS received a similar approval across the pond. The National Institute for Health and Care Excellence (NICE) ...

With only 12% 1 of therapies surviving the gauntlet of Phase III trials to receive FDA approval, and the cost to bring a drug ...

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli ...

Investment and strategic partnerships are the lifeblood of innovation in healthcare, driving groundbreaking discoveries and ...

A new report commissioned by the Association of the British Pharmaceutical Industry (ABPI) has found that hospitals engaging ...

If approved, the six manufacturers – Dr Reddy’s Laboratories Limited, Emcure, Eva Pharma, Ferozsons Laboratories Limited, ...

The approach can be transformative. When patients feel heard and understood, they’re more likely to engage actively and ...

HALIX, a Dutch contract development and manufacturing organisation (CDMO) specialising in complex therapeutic antibodies and ...

During pilot programmes, Concentriq Embeddings demonstrated its ability to significantly accelerate AI development. In one ...

Starting January 1, 2025, most Blue Shield commercial members using Fresenius Kabi's adalimumab-aacf (a Humira biosimilar) ...

In the third, final, and by most reckonings most inconsequential, national debate of the US presidential election, vice ...

In this interview, filmed at LSX 2024 at the Hynes Convention Center in Boston, Greenwood and Closed Loop CEO Hakim Yadi talk about why precision dosing is necessary and how the idea can support a ...